Clincosm LogoSign in Get a demo

clear cell renal cell carcinoma

Showing NaN - NaN of 22
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Clear Cell Renal Cell Carcinoma, Metastatic Malignant Tumor in the Bone, Metastatic Malignant Tumor in the Lymph Nodes Trial in

Recruiting
  • Clear Cell Renal Cell Carcinoma
  • +6 more
  • Anchorage, Alaska
  • +828 more
Feb 2, 2023

Clear Cell Renal Cell Carcinoma Trial in Worldwide (Belzutifan, Pembrolizumab, Placebo)

Recruiting
  • Clear Cell Renal Cell Carcinoma
  • Duarte, California
  • +250 more
Jan 27, 2023

Advanced Renal Cell Carcinoma, Chromophobe Renal Cell Carcinoma, Clear Cell Renal Cell Carcinoma Trial in United States (drug,

Recruiting
  • Advanced Renal Cell Carcinoma
  • +8 more
  • Cabozantinib S-malate
  • +3 more
  • Birmingham, Alabama
  • +35 more
Jan 24, 2023

Clear Cell Renal Cell Carcinoma Trial in United States (Batiraxcept, Cabozantinib (Cabo), Nivolumab)

Active, not recruiting
  • Clear Cell Renal Cell Carcinoma
  • Baltimore, Maryland
  • +16 more
Jan 17, 2023

Cancer of Kidney, Kidney Cancer, Renal Cancer Trial in New York (124-Iodine-cG250 (124I-cG250))

Completed
Has Results
  • Cancer of Kidney
  • +6 more
  • 124-Iodine-cG250 (124I-cG250)
  • New York, New York
    Memorial Sloan-Kettering Cancer Center
Oct 3, 2022

Advanced Solid Tumor, Clear Cell Renal Cell Carcinoma, Hepatocellular Carcinoma Trial in Korea, Republic of, Singapore, United

Recruiting
  • Advanced Solid Tumor
  • +3 more
  • Duarte, California
  • +22 more
Aug 17, 2022

Clear Cell Renal Cell Carcinoma, Metastatic Renal Cell Cancer, Recurrent Renal Cell Carcinoma Trial in United States

Active, not recruiting
  • Clear Cell Renal Cell Carcinoma
  • +3 more
  • Anti-OX40 Antibody PF-04518600
  • +3 more
  • Los Angeles, California
  • +9 more
Aug 5, 2022

ccRCC, RCC, Kidney Cancer Trial in United States (MK-3795, Nivolumab, Cabozantinib)

Active, not recruiting
  • ccRCC
  • +4 more
  • Los Angeles, California
  • +24 more
Jul 18, 2022

Solid Tumor, Clear Cell Renal Cell Carcinoma, TNBC - Triple-Negative Breast Cancer Trial in United States (CB-839, Talazoparib)

Terminated
Has Results
  • Solid Tumor
  • +6 more
  • Birmingham, Alabama
  • +8 more
Feb 16, 2022

Clear Cell Renal Cell Carcinoma, Kidney Cancer, Advanced Renal Cell Carcinoma Trial in United States

Recruiting
  • Clear Cell Renal Cell Carcinoma
  • +2 more
  • Basking Ridge, New Jersey
  • +6 more
Feb 16, 2022

Clear Cell Renal Cell Carcinoma, Stage I Renal Cell Cancer AJCC v6 and v7, Stage II Renal Cell Cancer AJCC v7 Trial in Canada,

Completed
Has Results
  • Clear Cell Renal Cell Carcinoma
  • +3 more
  • Laboratory Biomarker Analysis
  • +4 more
  • Birmingham, Alabama
  • +986 more
Jan 13, 2022

Mesothelioma, Bladder Cancer, Melanoma Trial in Australia, Canada, United States (MGD009)

Terminated
  • Mesothelioma
  • +12 more
  • MGD009
  • Los Angeles, California
  • +19 more
Feb 4, 2022

Clear Cell Renal Cell Carcinoma Trial in Korea, Republic of, United States (X4P-001, axitinib)

Active, not recruiting
  • Clear Cell Renal Cell Carcinoma
  • Scottsdale, Arizona
  • +19 more
Sep 20, 2021

Clear Cell Renal Cell Carcinoma Trial in United States (Placebo, CB-839, everolimus)

Completed
  • Clear Cell Renal Cell Carcinoma
  • Placebo
  • +2 more
  • Tucson, Arizona
  • +37 more
Aug 16, 2021

Clear Cell Renal Cell Carcinoma Trial in Worldwide (89Zr-girentuximab)

Recruiting
  • Clear Cell Renal Cell Carcinoma
  • 89Zr-girentuximab
  • Duarte, California
  • +29 more
Aug 4, 2021

Select Advanced Malignancies, Kidney Cancer, Clear Cell Renal Cell Carcinoma Trial in Worldwide (MEDI0680, Durvalumab,

Completed
Has Results
  • Select Advanced Malignancies
  • +2 more
  • MEDI0680
  • +2 more
  • Los Angeles, California
  • +26 more
May 6, 2021

Clear Cell Renal Cell Carcinoma, Metastatic Kidney Carcinoma, Stage III Renal Cell Cancer AJCC v7 Trial in United States

Completed
Has Results
  • Clear Cell Renal Cell Carcinoma
  • +3 more
  • Cabozantinib S-malate
  • +2 more
  • Mobile, Alabama
  • +487 more
Jan 28, 2021

Clear Cell Renal Cell Carcinoma, Metastatic Renal Cell Carcinoma, Stage I Renal Cell Cancer AJCC v6 and v7 Trial in New York

Terminated
  • Clear Cell Renal Cell Carcinoma
  • +5 more
  • Metastasectomy
  • +2 more
  • New York, New York
    Memorial Sloan Kettering Cancer Center
Oct 22, 2020

Clear Cell Renal Cell Carcinoma, Recurrent Renal Cell Carcinoma, Stage III Renal Cell Cancer AJCC v7 Trial in United States

Terminated
Has Results
  • Clear Cell Renal Cell Carcinoma
  • +3 more
  • Bevacizumab
  • +3 more
  • Scottsdale, Arizona
  • +523 more
Mar 5, 2019

Clear Cell Renal Cell Carcinoma, Recurrent Renal Cell Carcinoma, Stage IV Renal Cell Cancer AJCC v7 Trial in Peru, United States

Completed
Has Results
  • Clear Cell Renal Cell Carcinoma
  • +2 more
  • Bevacizumab
  • +4 more
  • Birmingham, Alabama
  • +558 more
Oct 15, 2018

Childhood Renal Cell Carcinoma, Clear Cell Renal Cell Carcinoma, Clear Cell Sarcoma of the Kidney Trial in Worldwide (drug,

Completed
Has Results
  • Childhood Renal Cell Carcinoma
  • +12 more
  • Doxorubicin Hydrochloride
  • +9 more
  • Birmingham, Alabama
  • +186 more
Jun 22, 2017

Accelerated Phase Chronic Myelogenous Leukemia, Acute Myeloid Leukemia With Multilineage Dysplasia Following Myelodysplastic

Completed
  • Accelerated Phase Chronic Myelogenous Leukemia
  • +84 more
  • sunitinib malate
  • +2 more
  • Los Angeles, California
  • +10 more
Mar 14, 2014